Your browser doesn't support javascript.
loading
Knowledge of disease, diagnosis, adherence and impact of research in an Irish cohort of patients with inflammatory arthritis.
Marzaioli, Viviana; Canavan, Mary; Donnelly, Alex; Wade, Siobhan; Fraser, Alexander; O'Sullivan, Tim; Harney, Sinead; Ireland, Arthritis; Veale, Douglas J; Fearon, Ursula.
Afiliação
  • Marzaioli V; Molecular Rheumatology, Trinity College Dublin, Dublin, Ireland.
  • Canavan M; EULAR Centre of Excellence, Centre for Arthritis and Rheumatic Diseases, St Vincent's University Hospital, Dublin, Dublin, Ireland.
  • Donnelly A; Molecular Rheumatology, Trinity College Dublin, Dublin, Ireland.
  • Wade S; EULAR Centre of Excellence, Centre for Arthritis and Rheumatic Diseases, St Vincent's University Hospital, Dublin, Dublin, Ireland.
  • Fraser A; Patient Advocate, Dublin, Ireland.
  • O'Sullivan T; Molecular Rheumatology, Trinity College Dublin, Dublin, Ireland.
  • Harney S; EULAR Centre of Excellence, Centre for Arthritis and Rheumatic Diseases, St Vincent's University Hospital, Dublin, Dublin, Ireland.
  • Ireland A; Dept of Rheumatology, University of Limerick, Limerick, Ireland.
  • Veale DJ; Patient Advocate, Dublin, Ireland.
  • Fearon U; Rheumatology Dept, Cork University Hospital, Cork, Ireland.
HRB Open Res ; 4: 60, 2021.
Article em En | MEDLINE | ID: mdl-37250112
ABSTRACT

Background:

Patient engagement with clinicians results in shared decision making and increased adherence to medication. However, in order for strong patient clinician partnerships to be achieved, communication barriers need to be identified. Therefore, the aim of this study was to examine the level of understanding of inflammatory arthritis patients and the need for strong patient-partnership in research.

Methods:

An online anonymous survey was distributed to patients living with inflammatory arthritis which addressed questions about diagnosis, routine tests, medications and how they work, medication adherence, disease flare, heredity, pregnancy, and patient involvement in research.

Results:

There were 1,873 respondents, 1416 of which had inflammatory arthritis (IA)- rheumatoid arthritis (RA) (65.8%) and psoriatic arthritis (PsA) (34.2%). They were predominantly female (RA 86%, PsA 85 %), aged 55±13 and 50±12 years. Less than 35% of patients had an understanding of diagnostic tests, what was measured and the implication for disease, with 75.5% also concerned about heredity. There was a high level of understanding of how specific medications treat inflammatory arthritis (72.9%). Adherence was also very high (>87%), with the main reasons for stopping medication without the advice of their clinician,  'feeling better' and 'side effects' however  a significant proportion of patients (69.9%) reported a disease-flare following cessation of medication. Patients (31%) were also concerned that inflammatory arthritis reduced their chances of getting pregnant, with only 8% believing arthritis medications were safe to take during pregnancy. Finally, only 9% of patients had ever been asked to participate in a research study.

Conclusions:

This study demonstrates a need for the development of stronger patient-partnerships with clinicians and researchers in relation to patient education and engagement with research, to create a platform where patients can have meaningful input and involvement in future research studies.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Prognostic_studies Idioma: En Revista: HRB Open Res Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Irlanda

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Prognostic_studies Idioma: En Revista: HRB Open Res Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Irlanda